v3.26.3
CONDENSED CONSOLIDATED STATEMENT OF CASH FLOWS (UNAUDITED) - USD ($)
$ in Millions
3 Months Ended 9 Months Ended
Sep. 30, 2026
Sep. 30, 2025
Sep. 30, 2026
Sep. 30, 2025
Cash flows from operating activities        
Cash from operations $ 246.7 $ 259.6 $ 693.7 $ 730.7
Income taxes paid (6.4) (7.7) (74.8) (38.7)
Payment for rent (0.2) (0.6) (0.2) (2.3)
Payment for tower and tower equipment decommissioning       (0.4)
Net cash from operating activities 240.1 251.3 618.7 689.3
Cash flow from investing activities        
Purchase of property, plant and equipment (28.9) (62.1) (100.1) (149.2)
Payment in advance for property, plant and equipment (29.6) (10.4) (42.1) (26.1)
Purchase of software and licenses (0.2)   (0.7) (0.1)
Proceeds from sale of subsidiaries, net of cash disposed 640.7   822.8  
Net (costs)/proceeds relating to disposal of property, plant and equipment (0.4) (1.9) 1.6 (0.1)
Insurance claims received 0.1 0.1 0.2 0.4
Interest received 15.2 11.2 39.9 31.8
Settlement of non-deliverable forwards (22.3)   (30.5)  
Deposit of short-term deposits (5.0) (0.5) (13.6) (16.3)
Refund of short-term deposits 7.1 20.3 9.0 29.8
Net cash from/(used in) investing activities 576.7 (43.3) 686.5 (129.8)
Cash flows from financing activities        
Proceeds received from issuance of borrowings (net of transaction costs) 207.9   207.9 195.9
Repayment of borrowings (216.7) (19.9) (258.3) (368.8)
Fees on borrowings and derivative instruments (1.9) (5.6) (6.4) (17.8)
Interest paid (35.8) (34.6) (166.3) (206.4)
Payment for the principal portion of lease liabilities (11.4) (11.3) (42.9) (34.8)
Interest paid for lease liabilities (14.6) (17.5) (49.0) (47.0)
Settlement of deliverable forwards   (3.3)   (3.3)
Interest paid on derivative instruments   (0.8)   (10.1)
Net cash used in financing activities (72.5) (93.0) (315.0) (492.3)
Net increase in cash and cash equivalents 744.3 115.0 990.2 67.2
Cash and cash equivalents at beginning of period 1,093.4 533.1 853.3 578.0
Exchange differences (1.4) 3.4 (7.2) 6.3
Cash and cash equivalents at end of period $ 1,836.3 $ 651.5 $ 1,836.3 $ 651.5